129 related articles for article (PubMed ID: 20464599)
1. Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
Allais G; Acuto G; Benedetto C; D'Andrea G; Grazzi L; Manzoni GC; Moschiano F; d'Onofrio F; Valguarnera F; Bussone G
Neurol Sci; 2010 Jun; 31 Suppl 1(Suppl 1):S115-9. PubMed ID: 20464599
[TBL] [Abstract][Full Text] [Related]
2. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Cady R
Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
4. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
[TBL] [Abstract][Full Text] [Related]
5. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
Bartolini M; Giamberardino MA; Lisotto C; Martelletti P; Moscato D; Panascia B; Savi L; Pini LA; Sances G; Santoro P; Zanchin G; Omboni S; Ferrari MD; Fierro B; Brighina F
J Headache Pain; 2012 Jul; 13(5):401-6. PubMed ID: 22592864
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Linder SL; Mathew NT; Cady RK; Finlayson G; Ishkanian G; Lewis DW
Headache; 2008 Oct; 48(9):1326-36. PubMed ID: 18484981
[TBL] [Abstract][Full Text] [Related]
7. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
9. Almotriptan for menstrually related migraine.
Bussone G; Allais G; Castagnoli Gabellari I; Benedetto C
Expert Opin Pharmacother; 2011 Aug; 12(12):1933-43. PubMed ID: 21726161
[TBL] [Abstract][Full Text] [Related]
10. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
11. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
[TBL] [Abstract][Full Text] [Related]
12. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study.
Zargaran A; Borhani-Haghighi A; Salehi-Marzijarani M; Faridi P; Daneshamouz S; Azadi A; Sadeghpour H; Sakhteman A; Mohagheghzadeh A
Neurol Sci; 2018 Aug; 39(8):1345-1353. PubMed ID: 29808331
[TBL] [Abstract][Full Text] [Related]
14. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
[TBL] [Abstract][Full Text] [Related]
15. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.
Bigal ME; Bordini CA; Tepper SJ; Speciali JG
Cephalalgia; 2002 Jun; 22(5):345-53. PubMed ID: 12110110
[TBL] [Abstract][Full Text] [Related]
16. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
17. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
18. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
[TBL] [Abstract][Full Text] [Related]
19. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
Láinez MJ; Galván J; Heras J; Vila C
Eur J Neurol; 2007 Mar; 14(3):269-75. PubMed ID: 17355546
[TBL] [Abstract][Full Text] [Related]
20. Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies.
Ashina M; Vasudeva R; Jin L; Lombard L; Gray E; Doty EG; Yunes-Medina L; Kinchen KS; Tassorelli C
Headache; 2019 Nov; 59(10):1788-1801. PubMed ID: 31529622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]